All Posts Tagged With: "ESRX"
(ABC) AmerisourceBergen Posts Modest Second Quarter Results
AmerisourceBergen Corporation (ABC) posted second quarter fiscal 2012 earnings of 81 cents per share, in line with the Zacks Consensus Estimate. However, earnings increased 5.2% from the year-ago period, spurred...
(CHSI) SXC Health Solutions to Buy Catalyst Health
On Wednesday, Catalyst Health Solutions Inc. (CHSI) announced that it has entered into a $4.4 billion takeover agreement with rival pharmacy benefits management (PBM) company, SXC Health Solutions...
(CVS) Management Churn at CVS Caremark
CVS Caremark Corporation (CVS) recently announced a change in top management. According to the company’s design, effective September 1, 2012, the present EVP and Chief Operating Officer of the Pharmacy Benefit...
(MHS) Medco Healh Analyst Reiterates Shares at Neutral
Recently, we reiterated our Neutral recommendation on Medco Health (MHS) with a target price of $74.00.
During the fourth quarter of fiscal 2011, Medco reported adjusted EPS of $1.25, beating the Zacks...
(ESRX) Company News for March 12, 2012 – Corporate Summary
• Starbucks Corporation (NASDAQ:SBUX) launched the latest espresso brewer and announced that the company will be selling single-cup coffee machines
• According to reports, the Federal Trade Commission...
(WAG) Walgreen Inks Deal with AARP
Leading drugstore chain Walgreen (WAG) recently entered into a three-year contract with a nonprofit organization AARP, to deliver retail drugstore program benefits to its members belonging to the 50-plus age...
(CVS) CVS Caremark Remains Neutral
Recently, we reiterated our Neutral recommendation on CVS Caremark Corporation (CVS) with a target price of $46.00.
CVS reported adjusted EPS of 89 cents in the fourth quarter of 2011 in line with the...
(CVS) CVS Caremark Corporation Ordered by FTC to Settle Claims
Recently CVS Caremark Corporation (CVS) was asked by the Federal Trade Commission (FTC) to pay $5 million to settle all claims related to the company’s misrepresentation of prices of certain...
(WAG) Walgreens 2012 First Quarter Earnings Scorecard
Subsequent to the announcement of Walgreen’s (WAG) first quarter 2012 (ended November 30) results on December 21, 2011, majority of the analysts have reduced their estimates for the forthcoming period.
Previous...
(ATHN) Grading the Investment U Gurus 2011: Marc Lichtenfeld
by Marc Lichtenfeld, Investment U Senior...
(ESRX) Walgreen Braves Express Scripts Loss
The six-month dispute with Express Scripts (ESRX) took its toll on Walgreen’s (WAG) recently released first quarter fiscal 2012 results....
(WAG) Walgreen Plans to Offset Express Scripts Loss
Walgreen (WAG) is commencing the New Year with efforts aimed at minimizing the impact of the non-renewal of the Express Scripts (ESRX) contract,...
(CVS) CVS Caremark Corporation to Attend Healthcare Conference
The leading provider of prescriptions and related health care services in the US, CVS Caremark Corporation (CVS) has decided to participate in the annual JP Morgan Healthcare Conference scheduled on January...
(ATHN) Grading the Investment U Gurus 2011: Marc Lichtenfeld
by Marc Lichtenfeld, Investment U Senior...
(CVS) CVS Caremark Launches New Pharmacy Advisor Program
CVS Caremark (CVS) recently launched a new Pharmacy Advisor program to help treat chronic cardiovascular illness.
The Pharmacy Advisor for chronic cardiovascular care will primarily focus on medication...
(MHS) Medco Analyst Maintains Shares at Neutral
Recently, we reiterated our Neutral recommendation on Medco Health (MHS) with a target price of $56.00.
During the third quarter of fiscal 2011, Medco reported adjusted EPS of $1.07, beating the Zacks...
(CVS) CVS Caremark Posts a Strong Quarter
CVS Caremark (CVS) reported third quarter 2011 EPS of 65 cents, 8.3% up year over year. However, after excluding the impact of certain one-time items, adjusted EPS came in at 70 cents, surpassing the Zacks...
(ESRX) Express Scripts Quarterly Report Beats by a Penny
Express Scripts Inc.’s (ESRX) third quarter 2011 earnings of 79 cents per share (excluding special items) were a penny above the Zacks Consensus Estimate and 22% above the year-ago adjusted earnings of...
(MHS) Medco Health Solutions and United Drug Terminate Joint Venture
Following the termination of the pan-European joint venture between Medco Health Solutions (MHS) and Germany-based Celesio AG, Dublin-based United Drug Plc recently decided to exit from its UK homecare partnership...
(WAG) Walgreen Posts Encouraging Quarter
Walgreen (WAG) reported adjusted earnings of 57 cents per share in the fourth quarter of fiscal 2011, beating the Zacks Consensus Estimate of 55 cents and were 38.3% higher than the year-ago quarter.
Results...
(AAPL) Company News for September 28, 2011 – Corporate Summary
• Rumors did the rounds that billionaire investor Carl Icahn might purchase a stake in Research In Motion Limited (NASDAQ:RIMM)
• According to reports, Apple Inc. (NASDAQ:
3Oct2011 | vitalstocks | 0 comments | Continued(WAG) Walgreen in Elite League
Recently, Walgreen (WAG) was ranked 29th among the top 30 technology innovators in the U.S, according to the 2011 Information Week 500. The company added another feather in its cap when it became...
(HWAY) Gallup-Healthways Report Well-Being
Healthways (HWAY), the well-being enhancement company, and statistical research services provider Gallup recently announced the results of the monthly Gallup-Healthways Well-Being Index (“WBI”)...
(WAG) Walgreen Ranked as Technology Innovator
Recently, Walgreen (WAG) was ranked 29th among the top 30 technology innovators in the U.S, according to the 2011 InformationWeek 500. The company added another feather in its cap when it became...
(WAG) Walgreen Joins U.S. Cardiac Program
Walgreen (WAG), the US Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention (CDC) and the Centers for Medicare and Medicaid Services (CMS) have teamed up in a campaign...
(FTC) Medco Health Solutions and Express Script Asked for More Information from Federal Trade Commission
Recently, Federal Trade Commission (FTC) requested both Medco Health Solutions (MHS) and Express Script (ESRX) to submit additional information...
(CVS) CVS Caremark Analyst Maintains Shares at Neutral
Recently, we reiterated our Neutral recommendation on CVS Caremark Corporation (CVS) with a target price of $38.00.
CVS reported an adjusted EPS of 65 cents in the second quarter of 2011, surpassing...
(CHSI) Catalyst Health Solutions Performs Well
Catalyst Health Solutions Inc. (CHSI) reported second-quarter operating earnings of 53 cents per share, at par with the Zacks Consensus Estimate. The results compare favorably with earnings of 46 cents in...
(ESRX) Express Scripts Revenue Rises – Earnings Report In Line
Express Scripts Inc.’s (ESRX) second quarter 2011 earnings of 71 cents per share (excluding special items) were in line with the Zacks Consensus Estimate but were well above the year-ago adjusted earnings...
(MHS) Express Scripts to Buy Medco Health Solutions
Following the release of its second quarter of fiscal 2011 earnings, Medco Health Solutions (MHS) announced that it will be acquired by Express Scripts (
4Aug2011 | vitalstocks | 0 comments | Continued